Kuhuang alleviates liver fibrosis by modulating gut microbiota-mediated hepatic IFN signaling and bile acid synthesis

Background: Liver fibrosis is a common outcome of the pathological progression of chronic liver disease; however, no specific and effective therapeutic agent has been approved for its treatment. We investigated the effects of Kuhuang on liver fibrosis and the underlying mechanisms of action. Materia...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Bo, Zhou, Cui, Gu, Tianyi, Shen, Zhenyang, Guo, Yuecheng, Dai, Weiming, Liu, Yang, Zhang, Jie, Lu, Lungen, Dong, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792617/
https://www.ncbi.nlm.nih.gov/pubmed/36582518
http://dx.doi.org/10.3389/fphar.2022.1080226

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792617/
https://www.ncbi.nlm.nih.gov/pubmed/36582518
http://dx.doi.org/10.3389/fphar.2022.1080226

Ejemplares similares